3 takeaways from our daily meeting: Stocks teeter, an oil trim, obesity drug fast track

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday's key moments. Stocks teeter Selling high, considering buying Quick mentions: LLY, COST 1. Stocks teeter Stocks swayed on Thursday after starting the week with sharp gains that puttered out by Wednesday.

We're eyeing Estee Lauder , which we believe will have a great next quarter, and Constellation Brands as stocks we could potentially buy into weakness. 3. Quick mentions: LLY, COST Here are updates on two Club names: The U.S. Food and Drug Administration fast tracked the approval process for Eli Lilly 's obesity treatment, which is already approved for type-2 diabetes. Jim reiterated his prediction that Tirzepatide could become "the greatest selling drug of all time.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

We're trimming one of our oil stocks that's up again after the big OPEC+ production cutOur plan is to take this extra cash and recycle it into other stocks that haven't made as strong of a move this week. Can't wait for Tuttle's inverse jimcramer ETF that begins trading in December. Don’t listen to Cramer Oh yeah... (See the Solar-Powered Florida Town That Didn't Lose Power During Ian)
Source: CNBC - 🏆 12. / 72 Read more »

Stocks waver as dollar eases, oil steadies on OPEC+ deal By ReutersStocks waver as dollar eases, oil steadies on OPEC+ deal The Fed should stop raising interest rates Fire him first otherwise he will definitely bring worldwide recession..!! Let's goooo!!!! Take all of my fun coupons
Source: Investingcom - 🏆 450. / 53 Read more »